« Big data » « Real world evidence » « patient data »…The digital revolution in healthcare and in the pharmaceutical industry has, among consequences, the creation of an enormous pile of data, with dimensions never seen before, up to 1 million time bigger than the amount of data they generated just 10 years ago. Hence, it is a real tsunami of data that is now arriving…How big is this tsunami? What are the consequences for the healthcare sector? What is the consequence for you, pharmaceutical industry? What can you do, you personally? How will this affect you? What can you do now, practically…? These are among the questions that will be addressed by Pierre in his introductory speech… Among others, Pierre will insist on the fact that instead of dreaming to big data, Big Pharma should first focus on smart data.
Mr. Pierre De Nayer co-founded Citobi SA (Which encompass Actito and MediQuality) in 2000. He is member of executive committee where he acts as managing director, with focus on MediQuality SA. He started his career by creating a company active in biotechnology (now acquired by GSK). Then, he joined Procter&Gamble Pharmaceuticals in 1994, as Key Account Manager. He served as consultant of McKinsey & Company from 1998 to 2000. Mr. De Nayer holds a degree in commercial sciences, obtained at HEC Brussels (ICHEC) in 1990, a degree in Molecular Biology (Biotechnology), obtained at the Free University of Brussels (ULB-1993) and a degree in Philosophy, obtained at the University of Louvain (2008).